Caxton Associates LLP Acquires New Stake in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Caxton Associates LLP has made a new investment in Sabra Healthcare REIT, Inc., purchasing 105,103 shares valued at approximately $1.84 million.
• Sabra Healthcare REIT reported a quarterly earnings per share of $0.38, beating analyst expectations, with revenue reaching $189.15 million, representing a year-over-year increase of 7.4%.
• The company declared a quarterly dividend of $0.30 per share, resulting in an annualized yield of 6.3%, despite a high dividend payout ratio of 157.89%.

Caxton Associates LLP purchased a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 105,103 shares of the real estate investment trust's stock, valued at approximately $1,836,000.

Other institutional investors have also made changes to their positions in the company. Allspring Global Investments Holdings LLC bought a new stake in shares of Sabra Healthcare REIT in the first quarter valued at approximately $298,000. New York State Teachers Retirement System boosted its stake in shares of Sabra Healthcare REIT by 12.1% in the first quarter. New York State Teachers Retirement System now owns 321,647 shares of the real estate investment trust's stock valued at $5,619,000 after buying an additional 34,591 shares during the period. M&T Bank Corp boosted its stake in shares of Sabra Healthcare REIT by 2.1% in the first quarter. M&T Bank Corp now owns 51,827 shares of the real estate investment trust's stock valued at $905,000 after buying an additional 1,059 shares during the period. Cambridge Investment Research Advisors Inc. boosted its stake in shares of Sabra Healthcare REIT by 4.7% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust's stock valued at $331,000 after buying an additional 853 shares during the period. Finally, Ethos Financial Group LLC bought a new stake in shares of Sabra Healthcare REIT in the first quarter valued at approximately $1,150,000. 99.40% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages recently issued reports on SBRA. Truist Financial boosted their price target on Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a research note on Tuesday, September 2nd. JMP Securities boosted their price objective on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research report on Wednesday, August 6th. Wells Fargo & Company boosted their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research report on Wednesday, August 27th. BMO Capital Markets boosted their price objective on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research report on Monday, August 25th. Finally, Scotiabank boosted their price objective on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $20.83.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ:SBRA traded down $0.08 during trading on Friday, hitting $19.05. 1,519,531 shares of the company were exchanged, compared to its average volume of 2,121,595. The business's 50 day moving average is $18.68 and its 200-day moving average is $17.99. The company has a market capitalization of $4.57 billion, a P/E ratio of 25.07, a price-to-earnings-growth ratio of 1.52 and a beta of 0.88. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 1-year low of $15.60 and a 1-year high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.02. The company had revenue of $189.15 million during the quarter, compared to the consensus estimate of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were issued a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.3%. Sabra Healthcare REIT's dividend payout ratio is 157.89%.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.